US 10308658
Salt of EGFR inhibitor, crystalline form and uses thereof
granted A61KA61K2300/00A61K31/337
Quick answer
US patent 10308658 (Salt of EGFR inhibitor, crystalline form and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2300/00, A61K31/337, A61K31/427, A61K31/436